Group One Trading
TTNP

Group One Trading’s Titan Pharmaceuticals TTNP Stock Holding History

Group One Trading’s Portfolio TTNP Stock Details TTNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-12
Closed -$58 – 9184
2025
Q3 		$58 Hold
12
– – ﹤0.01% 8261
2025
Q2 		$50 Hold
12
– – ﹤0.01% 7804
2025
Q1 		$42 Hold
12
– – ﹤0.01% 7429
2024
Q4 		$39 Hold
12
– – ﹤0.01% 7130
2024
Q3 		$64 Hold
12
– – ﹤0.01% 6490
2024
Q2 		$66 Hold
12
– – ﹤0.01% 6565
2024
Q1 		$86 Hold
12
– – ﹤0.01% 6849
2023
Q4 		$95 Hold
12
– – ﹤0.01% 7202
2023
Q3 		$107 Sell
12
-5
-29% -$54 ﹤0.01% 7472
2023
Q2 		$214 Hold
17
– – ﹤0.01% 7464
2023
Q1 		$273 Buy
17
+2
+13% +$36 ﹤0.01% 6974
2022
Q4 		$237 Buy
+15
New +$284 ﹤0.01% 7024
2022
Q3 		– Sell
-2,975
Closed -$33K – 8287
2022
Q2 		$33K Buy
2,975
+30
+1% +$374 ﹤0.01% 5917
2022
Q1 		$56K Buy
2,945
+707
+32% +$14.7K ﹤0.01% 6012
2021
Q4 		$46K Buy
2,238
+1,488
+198% +$44.8K ﹤0.01% 6407
2021
Q3 		$28K Sell
750
-726
-49% -$31.8K ﹤0.01% 6972
2021
Q2 		$77K Sell
1,476
-2,180
-60% -$109K ﹤0.01% 6203
2021
Q1 		$218K Buy
3,656
+3,616
+9,040% +$239K ﹤0.01% 4947
2020
Q4 		$3K Buy
40
+28
+233% +$2.21K ﹤0.01% 6184
2020
Q3 		$1K Hold
12
– – ﹤0.01% 5966
2020
Q2 		$2K Hold
12
– – ﹤0.01% 5579
2020
Q1 		$2K Hold
12
– – ﹤0.01% 5005
2019
Q4 		$1K Buy
+12
New +$1.45K ﹤0.01% 5001

Other funds holding TTNP

CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return
GWSA
Global Wealth Strategies & Associates Denver, Colorado $528M AUM 23.18% 1-Year Est. Return
CSC
Caldwell Sutter Capital Sausalito, California $246M AUM 23.62% 1-Year Est. Return
DJSG
D.J. St. Germain Springfield, Massachusetts $2.78B AUM 23.87% 1-Year Est. Return

Group One Trading's TTNP Position: Q4 2025 in Review

Group One Trading sold out of Titan Pharmaceuticals (TTNP) in Q4 2025, closing a stake of 12 shares — an estimated $58 sold.

Group One Trading first reported a position in TTNP in Q4 2019 and held it in 23 quarters. The position peaked at $218K in Q1 2021. 4 funds tracked by Wall St. Rank hold TTNP as of Q4 2025.

  • Group One Trading reported no remaining Titan Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Group One Trading sold 12 Titan Pharmaceuticals shares in Q4 2025, an estimated $58.
  • Group One Trading first reported a position in Titan Pharmaceuticals in Q4 2019 and held it in 23 quarters.
  • Group One Trading's Titan Pharmaceuticals position peaked at $218K in Q1 2021.
  • 4 funds tracked by Wall St. Rank held Titan Pharmaceuticals as of Q4 2025.

Based on Group One Trading's 13F filing for Q4 2025, filed 12 Feb 2026.